Taiyen Biotech Co (TPE:1737) Beneish M-Score: -2.41 (As of Jul. 10, 2026)


TPE:1737 Taiyen Biotech Co Ltd TPE:1737
83 GF Score
Price NT$31.90
GF Value NT$32.09
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Taiyen Biotech Co Beneish M-Score?

Taiyen Biotech Co TPE:1737 83 Beneish M-Score is -2.41 as of Jul. 10, 2026. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,848 Consumer Packaged Goods companies, Taiyen Biotech Co ranks worse than 59.47% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.41 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Taiyen Biotech Co's Beneish M-Score or its related term are showing as below:

TPE:1737' s Beneish M-Score Range Over the Past 10 Years
Min: -2.94   Med: -2.53   Max: -2.01
Current: -2.41

During the past 13 years, the highest Beneish M-Score of Taiyen Biotech Co was -2.01. The lowest was -2.94. And the median was -2.53.


Taiyen Biotech Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Taiyen Biotech Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiyen Biotech Co Beneish M-Score Chart

Taiyen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.27 -2.68 -2.64 -2.94 -2.41

Taiyen Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.94 -2.78 -2.73 -2.72 -2.41

TPE:1737 vs PG, CL, KVUE: Beneish M-Score Comparison

For the Household & Personal Products subindustry, Taiyen Biotech Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiyen Biotech Co Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Taiyen Biotech Co's Beneish M-Score falls into.


TPE:1737
83GF Score
Taiyen Biotech Co Ltd TPE:1737
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiyen Biotech Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Taiyen Biotech Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0295+0.528 * 1.0047+0.404 * 0.9847+0.892 * 1.0215+0.115 * 0.9144
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.963+4.679 * -0.003895-0.327 * 0.8362
=-2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$524 Mil.
Revenue was 816.452 + 814.822 + 857.197 + 819.189 = NT$3,308 Mil.
Gross Profit was 322.823 + 323.978 + 372.488 + 323.721 = NT$1,343 Mil.
Total Current Assets was NT$2,756 Mil.
Total Assets was NT$8,263 Mil.
Property, Plant and Equipment(Net PPE) was NT$4,119 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$246 Mil.
Selling, General, & Admin. Expense(SGA) was NT$822 Mil.
Total Current Liabilities was NT$960 Mil.
Long-Term Debt & Capital Lease Obligation was NT$27 Mil.
Net Income was 143.087 + 72.36 + 87.139 + 97.281 = NT$400 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 155.729 + 116.467 + 202.007 + -42.155 = NT$432 Mil.
Total Receivables was NT$498 Mil.
Revenue was 782.2 + 838.926 + 803.729 + 813.297 = NT$3,238 Mil.
Gross Profit was 305.671 + 333.468 + 348.588 + 333.181 = NT$1,321 Mil.
Total Current Assets was NT$2,927 Mil.
Total Assets was NT$8,381 Mil.
Property, Plant and Equipment(Net PPE) was NT$4,025 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$219 Mil.
Selling, General, & Admin. Expense(SGA) was NT$835 Mil.
Total Current Liabilities was NT$1,165 Mil.
Long-Term Debt & Capital Lease Obligation was NT$31 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(524.029 / 3307.66) / (498.296 / 3238.152)
=0.158429 / 0.153883
=1.0295

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1320.908 / 3238.152) / (1343.01 / 3307.66)
=0.40792 / 0.40603
=1.0047

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2756.224 + 4119.045) / 8262.561) / (1 - (2927.423 + 4024.665) / 8381.173)
=0.167901 / 0.170511
=0.9847

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3307.66 / 3238.152
=1.0215

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(218.593 / (218.593 + 4024.665)) / (245.922 / (245.922 + 4119.045))
=0.051515 / 0.05634
=0.9144

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(821.754 / 3307.66) / (835.392 / 3238.152)
=0.24844 / 0.257984
=0.963

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((26.563 + 959.885) / 8262.561) / ((31.488 + 1165.15) / 8381.173)
=0.119388 / 0.142777
=0.8362

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(399.867 - 0 - 432.048) / 8262.561
=-0.003895

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Taiyen Biotech Co has a M-score of -2.41 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.41 mean?
Taiyen Biotech Co (TPE:1737) has a Beneish M-Score of -2.41 as of Jul. 10, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Taiyen Biotech Co and its competitors. According to the industry distribution chart, Taiyen Biotech Co ranks #1099 out of 1848 companies in the Consumer Packaged Goods industry, placing it in the top 59.5%.
Is Taiyen Biotech Co's Beneish M-Score too high?
Taiyen Biotech Co's current Beneish M-Score is -2.41. Based on the distribution chart, Taiyen Biotech Co ranks #1099 out of 1848 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Beneish M-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #1099 out of 1848 companies for Beneish M-Score. This places Taiyen Biotech Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Taiyen Biotech Co and its competitors. Taiyen Biotech Co's current Beneish M-Score is -2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current Beneish M-Score is -2.41. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Beneish M-Score is -2.41 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?

Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued. The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09. GuruFocus considers Taiyen Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1737:

  • Beneish M-Score: -2.41
  • GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Taiyen Biotech Co Business Description

Address No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score

Get the complete analysis for TPE:1737

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.90
Price
NT$32.09
GF Value